Whitehawk Therapeutics (WHWK) Other Operating Expenses (2019 - 2025)
Historic Other Operating Expenses for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q3 2025 value amounting to -$177000.0.
- Whitehawk Therapeutics' Other Operating Expenses changed N/A to -$177000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $88.1 million, marking a year-over-year increase of 939902.91%. This contributed to the annual value of $3.0 million for FY2024, which is 765.4% up from last year.
- As of Q3 2025, Whitehawk Therapeutics' Other Operating Expenses stood at -$177000.0.
- In the past 5 years, Whitehawk Therapeutics' Other Operating Expenses registered a high of $87.4 million during Q1 2025, and its lowest value of -$177000.0 during Q3 2025.
- In the last 5 years, Whitehawk Therapeutics' Other Operating Expenses had a median value of $676500.0 in 2023 and averaged $14.2 million.
- In the last 5 years, Whitehawk Therapeutics' Other Operating Expenses tumbled by 9920.03% in 2022 and then surged by 31756.76% in 2023.
- Over the past 5 years, Whitehawk Therapeutics' Other Operating Expenses (Quarter) stood at $74.2 million in 2021, then crashed by 99.7% to $222000.0 in 2022, then soared by 317.57% to $927000.0 in 2023, then dropped by 14.78% to $790000.0 in 2024, then plummeted by 122.41% to -$177000.0 in 2025.
- Its Other Operating Expenses stands at -$177000.0 for Q3 2025, versus $87.4 million for Q1 2025 and $790000.0 for Q4 2024.